Covid-19: Slovenia suspends the use of Janssen vaccine after death

Slovenia suspended as a precaution, Wednesday, September 29, the use of the Janssen vaccine against Covid-19, produced by the American pharmaceutical company Johnson & Johnson, after the death of a 20-year-old woman.

“We are temporarily stopping until all the details related to this case are clarified”, announced the Minister of Health, Janez Poklukar, to the press in Ljubljana, the capital. According to Bojana Beovic, who heads the group of experts advising the government, “There could be an unwanted link between death and vaccination”.

Earlier, Slovenian media reported on the case of a 20-year-old woman hospitalized in serious condition on Monday, just days after receiving a dose of Johnson & Johnson’s single-dose vaccine. She succumbed to a brain hemorrhage and blood clots overnight from Tuesday to Wednesday.

Article reserved for our subscribers Read also Janssen: the disappointed hope of the single-dose vaccine

Demonstration in Ljubljana

A death has already been linked in the past to this vaccine in Slovenia, where compulsory vaccination goes into effect in the civil service on Friday 1er October, pushing more and more people to get vaccinated. With 47% of the population vaccinated, this country of 2 million inhabitants has a protection rate lower than the European Union average (64%).

Article reserved for our subscribers Read also Covid-19: 70% of European adults first-vaccinated, but a risk of a two-speed Europe

Wednesday evening, demonstrators, including the father of the girl according to media, gathered in the capital by the thousands to denounce the current health policy. They blocked a road axis and the police used tear gas to disperse them.

Police officers block the road during the demonstration against vaccination and health measures in Ljubljana, Slovenia on September 29, 2021.

By mid-September, the Slovenian police had already dispersed with water cannon and tear gas thousands of demonstrators who were protesting in Ljubljana for the same reasons.

The World with AFP

www.lemonde.fr

Leave a Comment